Skip to main content
Premium Trial:

Request an Annual Quote

Rockefeller Foundation, Pasteur Network Partner for Pathogen Surveillance, Sequencing

NEW YORK – The Rockefeller Foundation's Pandemic Prevention Institute (PPI) and the Pasteur Network announced on Wednesday that they have inked an agreement to build a decentralized global infectious disease surveillance network. 

The collaboration will incorporate pathogen surveillance and genomic sequencing in order to detect emerging and reemerging diseases. It aims to enhance the effectiveness of PPI and the Pasteur Network's 33 member institutions, the organizations said in a statement. 

Rick Bright, CEO of PPI, said that the collaboration "will undoubtedly make a transformational impact on global health security," by leveraging equitable data-sharing practices to provide stakeholders and decision-makers with timely, accurate, and relevant information. 

"Our collective aim is to advance access to pathogen surveillance, genomic sequencing, analytics, and data sharing tools in low- and middle-income countries and to foster sentinel laboratory networks for early disease detection," Bright said. 

The partnership will focus on advancing equitable data sharing, bolstering epidemiological and genomic surveillance in low- and middle-income countries, and advancing access to pathogen surveillance and analytical tools. It also aims to enhance discovery of emerging and reemerging high consequence pathogens and support interdisciplinary research projects addressing the causes of outbreaks and epidemics. 

The combined networks will maintain local and regional structures to foster a permanent operational force and share technologies, systems, practices, and techniques with their networks, PPI and Pasteur Network said. 

Amadou Sall, president of the Pasteur Network, called the memorandum of understanding "a major milestone" in its collaboration with PPI that could lead to "significant impact" in epidemic and pandemic preparedness. 

"Together, the Pasteur Network and PPI are an effective combination of complementary talents and capacity to address global health threats," Sall said. 

Last year, PPI committed more than $20 million to research funding and collaborations, dedicated in part to increasing sequencing-based pathogen surveillance.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.